Nkarta to Participate in a September Investor Conference
Nkarta (NASDAQ:NKTX), a clinical-stage biopharmaceutical company focused on engineered natural killer (NK) cell therapies, has announced its participation in the H.C. Wainwright 27th Annual Global Investment Conference. The company will engage in a fireside chat on September 9, 2025, at 8:30 a.m. ET.
Investors can access a live webcast of the presentation through Nkarta's website, with a replay available for approximately 90 days following the event.
Nkarta (NASDAQ:NKTX), azienda biofarmaceutica in fase clinica specializzata in terapie a base di cellule natural killer (NK) ingegnerizzate, ha annunciato la sua partecipazione al H.C. Wainwright 27th Annual Global Investment Conference. L'azienda parteciperà a una conversazione il 9 settembre 2025 alle 8:30 ET.
Gli investitori potranno seguire la presentazione in diretta streaming dal sito web di Nkarta; la registrazione sarà disponibile in replay per circa 90 giorni dopo l'evento.
Nkarta (NASDAQ:NKTX), una compañía biofarmacéutica en fase clínica centrada en terapias con células asesinas naturales (NK) modificadas, ha anunciado su participación en la H.C. Wainwright 27th Annual Global Investment Conference. La empresa participará en una charla el 9 de septiembre de 2025 a las 8:30 a.m. ET.
Los inversores podrán ver la presentación vía webcast en el sitio web de Nkarta; la repetición estará disponible durante aproximadamente 90 días después del evento.
Nkarta (NASDAQ:NKTX)는 엔지니어드 자연 살해(NK) 세포 치료제에 주력하는 임상 단계 바이오제약사로, H.C. Wainwright 27th Annual Global Investment Conference에 참가한다고 발표했습니다. 회사는 2025년 9월 9일 오전 8:30(동부 표준시)에 대담에 참여합니다.
투자자들은 Nkarta 웹사이트를 통해 발표를 실시간 웹캐스트로 시청할 수 있으며, 행사 이후 약 90일간 다시보기(replay)를 이용할 수 있습니다.
Nkarta (NASDAQ:NKTX), société biopharmaceutique en phase clinique spécialisée dans les thérapies par cellules natural killer (NK) modifiées, a annoncé sa participation à la H.C. Wainwright 27th Annual Global Investment Conference. La société prendra part à une discussion le 9 septembre 2025 à 8h30 (heure de l'Est).
Les investisseurs pourront suivre la présentation en webdiffusion en direct via le site de Nkarta ; un replay sera disponible pendant environ 90 jours après l'événement.
Nkarta (NASDAQ:NKTX), ein biopharmazeutisches Unternehmen in der klinischen Entwicklungsphase mit Fokus auf gentechnisch veränderte Natural-Killer-(NK)-Zelltherapien, hat seine Teilnahme an der H.C. Wainwright 27th Annual Global Investment Conference angekündigt. Das Unternehmen wird an einem Fireside-Chat am 9. September 2025 um 8:30 Uhr ET teilnehmen.
Investoren können die Präsentation per Live-Webcast über die Nkarta-Website verfolgen; eine Aufzeichnung wird etwa 90 Tage nach der Veranstaltung zum Abruf bereitstehen.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conference:
H.C. Wainwright 27th Annual Global Investment Conference
September 9, 2025
8:30 a.m. ET – fireside chat
A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately 90 days.
About Nkarta
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for autoimmune diseases. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep therapeutic activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website at www.nkartatx.com.
Nkarta Media/Investor Contact:
Nadir Mahmood
Nkarta, Inc.
nmahmood@nkartatx.com
FAQ
When is Nkarta (NKTX) presenting at the H.C. Wainwright Conference?
How can investors access Nkarta's (NKTX) H.C. Wainwright Conference presentation?
What is Nkarta's (NKTX) main focus as a company?
How long will the replay of Nkarta's (NKTX) conference presentation be available?
